AbbVie (ABBV) Current Assets (2012 - 2026)
AbbVie's Current Assets came in at $33.67 billion for Q2 2026, up 15.1% from $29.26 billion a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Current Assets was $29.06 billion, up 13.6% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 3.8% (FY2020 to FY2025).
- Going back by year, Current Assets was $25.58 billion in FY2024 (-22.5%), $33 billion in FY2023 (+15.9%), $28.46 billion in FY2022 (+1.9%) and $27.93 billion in FY2021 (+15.5%).
- The Q2 2026 figure represents the highest quarterly Current Assets since Q2 2024.
- Year-over-year, Current Assets has increased for four consecutive quarters, with an average decline of 3.6% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q1 2024 (growth of 46.7%), and the weakest in Q1 2025 (a decline of 28.8%).
- Business Quant data shows ABBV's Current Assets at $33.53 billion (Q1 2026), $29.06 billion (Q4 2025) and $28.54 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 12.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.67 Bn |
| Mar 31, 2026 | 33.53 Bn |
| Dec 31, 2025 | 29.06 Bn |
| Sep 30, 2025 | 28.54 Bn |
| Jun 30, 2025 | 29.26 Bn |
| Mar 31, 2025 | 27.68 Bn |
| Dec 31, 2024 | 25.58 Bn |
| Sep 30, 2024 | 27.79 Bn |
| Jun 30, 2024 | 33.82 Bn |
| Mar 31, 2024 | 38.87 Bn |
| Dec 31, 2023 | 33.00 Bn |
| Sep 30, 2023 | 33.22 Bn |
| Jun 30, 2023 | 28.85 Bn |
| Mar 31, 2023 | 26.49 Bn |
| Dec 31, 2022 | 28.46 Bn |
| Sep 30, 2022 | 30.36 Bn |
| Jun 30, 2022 | 29.10 Bn |
| Mar 31, 2022 | 26.51 Bn |
| Dec 31, 2021 | 27.93 Bn |
| Sep 30, 2021 | 28.96 Bn |
API Access
AbbVie Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();